- Home
- LTRN vs ANEB Comparison
LTRN vs ANEB Comparison
Compare LTRN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- ANEB
- Stock Information
- Founded
- LTRN 2013
- ANEB 2020
- Country
- LTRN United States
- ANEB United States
- Employees
- LTRN N/A
- ANEB N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- LTRN Health Care
- ANEB Health Care
- Exchange
- LTRN Nasdaq
- ANEB Nasdaq
- Market Cap
- LTRN 36.0M
- ANEB 39.0M
- IPO Year
- LTRN 2020
- ANEB 2021
- Fundamental
- Price
- LTRN $3.37
- ANEB $1.68
- Analyst Decision
- LTRN Strong Buy
- ANEB Strong Buy
- Analyst Count
- LTRN 1
- ANEB 2
- Target Price
- LTRN $25.00
- ANEB $5.50
- AVG Volume (30 Days)
- LTRN 51.0K
- ANEB 17.0K
- Earning Date
- LTRN 08-07-2025
- ANEB 05-13-2025
- Dividend Yield
- LTRN N/A
- ANEB N/A
- EPS Growth
- LTRN N/A
- ANEB N/A
- EPS
- LTRN N/A
- ANEB N/A
- Revenue
- LTRN N/A
- ANEB N/A
- Revenue This Year
- LTRN N/A
- ANEB N/A
- Revenue Next Year
- LTRN N/A
- ANEB N/A
- P/E Ratio
- LTRN N/A
- ANEB N/A
- Revenue Growth
- LTRN N/A
- ANEB N/A
- 52 Week Low
- LTRN $2.55
- ANEB $0.80
- 52 Week High
- LTRN $6.12
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- LTRN 50.26
- ANEB 65.22
- Support Level
- LTRN $3.09
- ANEB $1.36
- Resistance Level
- LTRN $3.31
- ANEB $2.46
- Average True Range (ATR)
- LTRN 0.17
- ANEB 0.26
- MACD
- LTRN 0.02
- ANEB 0.03
- Stochastic Oscillator
- LTRN 72.64
- ANEB 37.20
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.